Floatz logo

Panobinostat

Gallbladder Cancer

New Mexico Cancer Research AllianceSmall moleculePhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

11 Active assets in the Gallbladder Cancer cohort.

Asset / SponsorPhaseRating
Eloxatin
Tianjin Medical University Cancer Institute and Hospital
Phase 3BBB
FLUOROURACILUM
Lisata Therapeutics, Inc.
Phase 2BBB
Calcium folinate pentahydrate
Lisata Therapeutics, Inc.
Phase 2BB
Capecitabine
Merck Sharp & Dohme LLC
Phase 3BB
CIS-DIAMMINEDICHLOROPLATINUM II
Lisata Therapeutics, Inc.
Phase 2BB

View all 33 →

Same molecule, other indications

Panobinostat is also rated in:

Hodgkins lymphomaDormant
BB
Indicative ·
68 / 100
View asset →
Non-Small Cell Lung CancerDormant
BB
Indicative ·
66 / 100
View asset →
chronic lymphocytic leukemia/small lymphocytic lymphomaDormant
BB
Indicative ·
66 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →